Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1965 Jan 9;1(5427):89–92. doi: 10.1136/bmj.1.5427.89

An Investigation of Tropical Splenomegaly at Mulago Hospital, Kampala, Uganda

P D Marsden, M S R Hutt, N E Wilks, A Voller, V Blackman, K K Shah, D H Connor, P J S Hamilton, J G Banwell, H F Lunn
PMCID: PMC2165011  PMID: 14218486

Full text

PDF
89

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATKINSON M., SHERLOCK S. Intrasplenic pressure as index of portal venous pressure. Lancet. 1954 Jun 26;266(6826):1325–1327. doi: 10.1016/s0140-6736(54)92212-6. [DOI] [PubMed] [Google Scholar]
  2. CHARMOT G., VARGUES R. [The etilogy of macroglobulinemias observed in Africa]. Sem Hop. 1963 Jun 8;39:1421–1425. [PubMed] [Google Scholar]
  3. CHAUDHURI R. N., SAHA T. K., BASU S. P., MUKHERJEE A. M., CHAUDHURI M. N. R. Chronic splenomegaly. Indian J Med Res. 1956 Apr;44(2):305–323. [PubMed] [Google Scholar]
  4. FAWDRY A. L. Syndrome of splenomegaly, anaemia, and hepatomegaly often left-lobed, in South Arabia. Trans R Soc Trop Med Hyg. 1955 Jul;49(4):387–398. doi: 10.1016/0035-9203(55)90062-6. [DOI] [PubMed] [Google Scholar]
  5. GEBBIE D. A., HAMILTON P. J., HUTT M. S., MARSDEN P. D., VOLLER A., WILKS N. E. MALARIAL ANTIBODIES IN IDIOPATHIC SPLENOMEGALY IN UGANDA. Lancet. 1964 Aug 22;2(7356):392–393. doi: 10.1016/s0140-6736(64)90396-4. [DOI] [PubMed] [Google Scholar]
  6. HOLZBACH R. T., SHIPLEY R. A., CLARK R. E., CHUDZIK E. B. INFLUENCE OF SPLEEN SIZE AND PORTAL PRESSURE ON ERYTHROCYTE SEQUESTRATION. J Clin Invest. 1964 Jun;43:1125–1135. doi: 10.1172/JCI104997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HUGHES JONES N. C., SZUR L. Determination of the sites of red-cell destruction using 51Cr-labelled cells. Br J Haematol. 1957 Jul;3(3):320–331. doi: 10.1111/j.1365-2141.1957.tb05802.x. [DOI] [PubMed] [Google Scholar]
  8. LEATHER H. M. Portal hypertension and gross splenomegaly in Uganda. Br Med J. 1961 Jan 7;1(5218):15–18. doi: 10.1136/bmj.1.5218.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MARSDEN P. D., HUTT M. S., BANWELL J. G. ABNORMAL SPLENOVENOGRAMS IN NON-CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION AND MARKED SPLENOMEGALY. J Trop Med Hyg. 1964 Oct;67:239–245. [PubMed] [Google Scholar]
  10. MOLLISON P. L., VEALL N. The use of the isotope 51Cr as a label for red cells. Br J Haematol. 1955 Jan;1(1):62–74. doi: 10.1111/j.1365-2141.1955.tb05489.x. [DOI] [PubMed] [Google Scholar]
  11. VOLLER A. FLUORESCENT ANTIBODY METHODS AND THEIR USE IN MALARIA RESEARCH. Bull World Health Organ. 1964;30:343–354. [PMC free article] [PubMed] [Google Scholar]
  12. WALTERS J. H., McGREGOR I. A. The mechanism of malarial hepatomegaly and its relationship to hepatic fibrosis. Trans R Soc Trop Med Hyg. 1960 Mar;54:135–145. doi: 10.1016/0035-9203(60)90050-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES